#Fungal Pneumonia market forecast | Explore Tumblr Posts and Blogs

healthcare-domain · 1 year

Text

Sepsis Diagnostics Market Growth Drivers & Opportunities | MarketsandMarkets

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for sepsis diagnostic research activities, the growing burden of infectious diseases, the rising number of sepsis incidences, and growing government initiatives for creating sepsis awareness.

Sepsis is a very difficult condition to diagnose and the risk of mortality increases by 7.6% with a delay of even 1 minute in antibiotic administration in septic shock patients with hypertension. Thus, increasing the need for the rapid diagnosis of sepsis to reduce the delay of antibiotic therapy among patients with sepsis. Many sepsis diagnostic manufacturers are expanding their product offering in point of care technology rapidly detecting the sepsis, reducing the overall turnaround time of diagnosis.

The BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing instruments manufactured by BD Company (US) is an automated microbial detection system offering a rapid diagnosis of sepsis in the turnaround time of three hours.

According to the new market research report "Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay, Instruments, Software), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), End User (Hospital, Pathology Lab) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9% from 2021 to 2026.

Browse in-depth TOC on "Sepsis Diagnostics Market" 201 – Tables 47 – Figures 236 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the rising prevalence of sepsis across the globe. Factors such as the increasing geriatric population, a growing number of surgical procedures, a high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are expected to drive market growth.

The COVID-19 pandemic had a positive effect on the sales of diagnostics products for sepsis. The global spread of covid-19 and the emerging cases of sepsis among covid-19 patients are likely to increase the demand for rapid diagnosis, accelerating the utilization of instruments, reagents, assay kits for detection of sepsis. Lockdowns resulting from the pandemic caused people to delay undergoing health checkups, affecting the number of tests performed and reagent sales.

The shortage of skilled professionals is a major concern worldwide; only 50% of patients with severe sepsis transported by the EMS system have a paramedic. The lack of trained paramedics affects each phase of patient caremdash;sepsis awareness, screening patients for the presence of sepsis, and making an appropriate.

The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually due to pneumonia, which increases the risk of developing sepsis. Thus, increasing the need for early diagnosis of sepsis among patients with covid-19 infections.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155

Based on technology, the biomarkers segment is expected to register the highest growth rate during the forecast period

Based on technology, the global sepsis diagnostics market is segmented into microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to various advantages offered by this technique in the diagnosis of sepsis and the growing need for early disease diagnosis.

North America accounted for the largest share of the sepsis diagnostics market

Geographically, the sepsis diagnostic market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to account for the largest share of the market. This can be attributed to the growing prevalence of sepsis, increasing incidence of hospital-acquired infections, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

0 notes

healthcaredbmrnews · 2 years

Link

The healthcare-associated infection (HAI) market is expected to witness market growth at a rate of 34.62% in the forecast period of 2022 to 2029

0 notes

globalmarketsresearchreports · 2 years

Text

Global Hospital Acquired Infections Testing Kits Market Competitive Strategies and Forecasts to 2031

The Hospital Acquired Infections Testing Kits Global Market Report 2021-31 by The Business Research Company describes and explains the global hospital acquired infections testing kits market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The Hospital Acquired Infections Testing Kits Global Market Report 2022 covers hospital acquired infections testing kits market drivers, hospital acquired infections testing kits market trends, hospital acquired infections testing kits market segments, hospital acquired infections testing kits market growth rate, hospital acquired infections testing kits market major players, and hospital acquired infections testing kits market size.

View Complete Report:

The hospital acquired infections testing kits market report provides in-depth analysis of the impact of COVID-19 on the global hospital acquired infections testing kits industry along with revised market numbers due to the effects of the coronavirus and the expected hospital acquired infections testing kits market growth numbers for 2022-2031.

The global hospital acquired infections testing kits market size is expected to grow from $1.12 billion in 2021 to $1.27 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%. The global hospital acquired infection testing kit market share is expected to grow to $1.78 billion in 2026 at a CAGR of 8.8%.

Request Report Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Hospital Acquired Infections Testing Kits Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

TBRC’s report covers the hospital acquired infections testing kits market segments- 1) By Product: Instrument and Reagents, Consumables

2) By Test Type: Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA Infection, Others

3) By Application: Drug-Resistance Testing, Disease Testing

4) By Pathogen Type: Viral, Bacterial, Fungal

5) By Method of Treatment: Sterilization, Chemical, Radiation

Table Of Contents

1. Executive Summary

2. Hospital Acquired Infections Testing Kits Market Characteristics

3. Hospital Acquired Infections Testing Kits Market Trends And Strategies

4. Impact Of COVID-19 On Hospital Acquired Infections Testing Kits

5. Hospital Acquired Infections Testing Kits Market Size And Growth

26. Africa Hospital Acquired Infections Testing Kits Market

27. Hospital Acquired Infections Testing Kits Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Hospital Acquired Infections Testing Kits Market

29. Hospital Acquired Infections Testing Kits Market Future Outlook and Potential Analysis

30. Appendix

About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information: The Business Research Company Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Find us on

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany/

Blog: http://blog.tbrc.info/

0 notes

blogbyshivani · 2 years

Text

Global Antifungal Drugs Market Size, Share, Trends, Growth & COVID-19 Impact Analysis Report – Industry Forecast (2021 to 2028)

The global Antifungal Drugs Market was valued at US$ XX billion in 2020, and it is expected to reach US$ XX billion by 2028, rising at a CAGR of XX percent over the forecast period (2021-2028). Antifungals are medications that cure fungal infections by interfering with the creation of the fungal cell membrane, cell wall components, membrane permeability, and nucleic acid synthesis, as well as the fungi's mitotic spindle activity during cell division.

While the majority of fungal infections affect the skin and nails, some can develop to more serious and possibly fatal illnesses such as meningitis or pneumonia. Market Trends for Antifungal Drugs.

Read more @ https://cmilatestinsights.blogspot.com/2022/01/global-antifungal-drugs-market-size.html

#Antifungal Drugs Market #coherent market inisights

0 notes

industry365 · 2 years

Text

Meningitis Diagnosis and Treatment Market Is Expected To Reach New Growth Revenues During 2021-2028

The Meningitis Diagnosis and Treatment Market size is anticipated to reach over USD 157.8 million by 2026. In 2017, the bacterial type dominated the global market, in terms of revenue. Asia-Pacific is expected to be the fastest growing contributor to the global market revenue in 2017.

Swelling to the meninges is known as meningitis. Meningitis affects the meninges, the membranes that covers spinal cord and brain that protect the central nervous system (CNS) along with the cerebrospinal fluid. Meningitis can cause by bacteria, fungal and virus. Bacterial infection is the most common meningitis. Some of the bacteria that can cause bacterial meningitis are Group B Streptococcus and Streptococcus pneumoniae (S. pneumoniae). Other types of meningitis are non-infectious meningitis, viral, parasitic, and fungal. However, the bacterial type is the most lethal which is considered as life-threatening type.

Other factors causing meningitis are HIV, tuberculosis, and certain illness. According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV) is major infectious disease. According to the same reports, around 36.7 million people across the globe were living with HIV during 2017. Such high prevalence of transferable illnesses is expected to drive the demand for diagnostic tests. Meningitis diagnostic test are carried out on human samples in order to prevent meningitis and/or diagnose meningitis and regulate drug therapies.

The growing investments on the R&D for efficient diagnosis and the treatment of such critical disease and rising occurrence of meningitis cases are the major factors estimated to boost the growth of the market. In addition, development of new technologies as well as devices and continuous growth of the medical device sector are other factors driving the market growth. However, strict regulatory guidelines and unawareness regarding the treatments and diagnosis are estimated to hamper the market growth.

Download sample: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-sample

The industry is segmented on the basis of type, diagnostic test, end user, and geography. Based on type, the market is bacterial, viral and fungal. on the basis of diagnostic tests, the market is segmented into PCR Assay, Lateral Flow Assay, Latex Agglutination Tests, ELISA Tests, and Culture Test. By end user, the market is further bifurcated as hospitals, diagnostic centers and others.

The market for meningitis diagnosis and treatment in North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period. Availability of technologically advanced devices as well as high adoption rate for such diagnosis devices, and the increasing investment on early diagnosis of diseases are major factors associated with the high market share in the region. Additionally, upsurge in the awareness regarding several brain disease including meningitis among the patients estimated to bolster the market growth in North America.

Asia Pacific is estimated to be the fastest growing region in terms of revenue. High occurrence of people suffering from meningitis along with increasing focus early diagnosis and treatment for the disease, provides significant growth opportunities of the market in APAC.

The major key players operating in the meningitis diagnosis and treatment industry include Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Get Discount offer: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-discount-pricing

Polaris Market Research has segmented the global Meningitis Diagnosis and Treatment Market on the basis of type, diagnostic test, end user and region: Meningitis Diagnosis and Treatment by Type Outlook (Revenue, USD Million, 2015 – 2026)

Bacterial

Fungal

Viral

Meningitis Diagnosis and Treatment by Diagnostic Test Outlook (Revenue, USD Million, 2015 – 2026)

PCR Assay

Lateral Flow Assay

Latex Agglutination Tests

ELISA Tests

Culture Test

Meningitis Diagnosis and Treatment by End-User Outlook (Revenue, USD Million, 2015 – 2026)

Hospitals

Diagnostic Centers

Others

Meningitis Diagnosis and Treatment Regional Outlook (Revenue, USD Million, 2015 – 2026)

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

U. S.

Canada

Germany

France

Italy

Spain

Belgium

Russia

Netherlands

Rest of Europe

China

India

Japan

Korea

Singapore

Malaysia

Indonesia

Thailand

Philippines

Brazil

Mexico

Argentina

Rest of LATAM

UAE

Saudi Arabia

South Africa

Rest of MEA

Buy Now: https://www.polarismarketresearch.com/checkouts/5441

0 notes

vicky8588 · 3 years

Text

23-Valent Pneumococcal Polysaccharide Vaccine Market, Size, Share

Market Overview

Pneumococcal is an infectious disease affected by the streptococcus pneumoniae bacteria, which may cause different illnesses such as ear infections, meningitis, and others. Pneumococcal polysaccharide vaccines are advised mostly for adults who suffer from pneumococcal infection.

The global 23-valent pneumococcal polysaccharide vaccine market size was valued US$ YY billion in 2020 and is estimated to reach US$ YY billion by 2028, growing at a CAGR of YY % during the forecast period (2021-2028)

Download free sample: https://www.datamintelligence.com/download-sample/23-valent-pneumococcal-polysaccharide-vaccine-market

Market Dynamics

Growing number of pneumococcal diseases associated with chronic disease patients is expected to drive the market growth.

According to the American Lung Association, Pneumococcal pneumonia is a potentially serious disease that can cause a range of different illnesses, including sinusitis, otitis media, pneumonia, bacteremia, osteomyelitis, septic arthritis and meningitis. Sinusitis affects 1 out of every seven adults in the United States, with more than 30 million individuals diagnosed each year. Moreover, the immune system naturally weakens with age, so even if you're healthy and active, being 65 or older is a key risk factor for pneumococcal pneumonia leading to an increased risk of chronic conditions, including COPD, Asthma, and heart disease Disease and Diabetes. Therefore it has led to an increase in the demand for the 23-Valent pneumococcal polysaccharide vaccine, which is expected to drive the market in the forecast period.

Side effects of PNEUMOVAX 23 (Pneumococcal Vaccine Polyvalent) are expected to hamper the market growth.

According to Merck, PNEUMOVAX 23 is a vaccine that is given as a shot. It helps protect from infection by certain germs or bacteria, which are called pneumococcus. Moreover, Pneumovax 23 vaccine is important for preventing infection in individuals at risk, including those with heart disease, lung disease, liver disease, kidney disease, diabetes, alcoholism, cirrhosis, spleen problems, sickle cell anemia, HIV, certain cancers, adults over 65 years of age. But the vaccine may not protect everyone who gets it, and it will not protect against diseases caused by bacteria types that are not in the vaccine. Besides the benefits of the vaccine, there are few side effects, including pain, warmth, soreness, redness, swelling, and hardening at the injection site, headache, weakness and feeling tired, and muscle pain. Thus, from the above statements, the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The coronavirus disease 2019 (COVID-19) pandemic is associated with high morbidity and mortality. Evidence shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is originally transmitted through respiratory droplets from symptomatic, asymptomatic, or pre-symptomatic individuals. Like other respiratory pathogens, such as influenza, where approximately 25% of older patients get secondary bacterial infections, both superinfections and co-infections with SARS-CoV-2 have been reported. However, there is limited data on the frequency of co-infection and superinfections by viral, bacterial, or fungal infections and associated clinical outcomes among patients infected with SARS-CoV-2.

Moreover, the co-infection acts as the recovery of other respiratory pathogens in patients with SARS-CoV-2 infection at the time of a SARS-CoV-2 infection diagnosis and superinfection as the subsequent recovery of other respiratory pathogens during care for SARS-CoV-2 infection. Two previous reviews have examined the prevalence of bacterial and fungal co-infection or superinfection in SARS-CoV-2 infected patients. In addition, prior work suggests outcome differences in patients with co-infections vs. superinfections. For instance, Garcia-Vidal et al. showed that SARS-CoV-2 infected patients with superinfections had a longer hospital stay (LOS) and higher mortality. In contrast, those with co-infections had a higher frequency of admission to the ICU. Diagnostic testing and therapeutic decision-making may be altered by the presence of co-infection or superinfection with SARS-CoV-2 and other respiratory pathogens.

Additionally, the market faces challenges in manufacturing and delivering drugs due to an interrupted supply chain. Providing essential services due to lockdowns has led to reduced supply to the end-users. The pandemic is not likely to have long-term effects on end-users primary growth in the 23-valent pneumococcal polysaccharide vaccine market.

Segment Analysis

– By Age-Group

Children (2-10 years)*

Adults (10-64 years)

Geriatrics (65 years and above)

– By Dose Type

Single Dose Vial*

Pre-Filled Syringe

Geographical Analysis

North America region holds the largest market share in the global 23-valent pneumococcal polysaccharide vaccine market.

North America accounted for the largest revenue share in 2020. The growth is attributed to the high prevalence of bacterial pneumonia, well established vaccination program in the region, increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players, the largest supplier and consumption market of 23-valent pneumococcal polysaccharide vaccine, are the major factors that the market is expected to boost the forecast period. For instance, according to the American Lung Association, The most common type of bacterial pneumonia is called pneumococcal pneumonia. Pneumococcal pneumonia is caused by the Streptococcus pneumoniae germ that normally lives in the upper respiratory tract. It infects over 900,000 Americans every year. The greatest risk for bacterial pneumonia includes people recovering from surgery, people with respiratory disease or viral infection, and weakened immune systems.

Moreover, it causes more than a million hospitalizations and more than 50,000 deaths each year. Therefore, it has increased the demand for the 23-Valent pneumococcal polysaccharide vaccine, due to which the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

The 23-valent pneumococcal polysaccharide vaccine market is vast with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Merck & Co., AstraZeneca, Baxter International Inc., Biogen Inc., Serum Institute of India, Eli Lilly and Company and Beijing Minhai Biotechnology. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the 23-valent pneumococcal polysaccharide vaccine market globally.

Merck & Co.:

Overview:

Merck & Co., Inc., outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891. The company develops and produces medicines, vaccines, biological therapies and animal health products. It has multiple blockbuster drugs or products, each with 2020 revenues, including cancer immunotherapy, anti-diabetic medication and vaccines against HPV and chickenpox. Moreover, the company is ranked 69th on the 2021 Fortune 500 and 92nd on the 2021 Forbes Global 2000, both based on 2020 revenues.

View full report: https://www.datamintelligence.com/research-report/23-valent-pneumococcal-polysaccharide-vaccine-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/23-valent-pneumococcal-polysaccharide-vaccine-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

#medicine #drugs #pharmaceutical

0 notes

newsinsights · 3 years

Text

Allergy Diagnostics Market Industry Growth, Top Players, Geography and Global Forecast 2031

A recent market study published by Future Market Insights on the allergy diagnostics market offers global industry analysis for 2017-2022 & opportunity assessment for 2021–2031. The study offers a comprehensive assessment of the more important market dynamics.

After conducting thorough research on the historical and current growth parameters of the allergy diagnostics market, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The allergy diagnostics market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Product Type

Fungal Allergy Diagnostic

Neutral Lactase Enzymes

By Allergen Type

Inhaled Allergens

Food Allergens

Drug Allergens

Other Allergens

By Test Type

In-vivo allergy tests

In-vitro allergy tests

By End User

Diagnostic Laboratories

Hospitals

Academic Research Institutes

Other End Users

Region

North America

Latin America

Europe

East Asia

South Asia

Middle East and Africa

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

Chapter 01 – Executive Summary

The executive summary of the allergy diagnostics market includes the market proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the allergy diagnostics market.

Chapter 02 – Market Overview

Readers can find the detailed segmentation and definition of the allergy diagnostics market in this chapter, which will help them understand basic information about the allergy diagnostics market. This section also highlights the inclusions and exclusions, which help the reader, understand the scope of the allergy diagnostics market report.

Chapter 03 – Market Background

The associated industry assessment of the allergy diagnostics market is carried out in this section. The macroeconomic factors affecting the growth of the allergy diagnostics market are provided in this section and the impact of these macroeconomic indicators on the allergy diagnostics market is analyzed. The processing overview and technological advancements in the allergy diagnostics market are also provided.

Chapter 04 – Allergy Diagnostics Market Value Chain

Profit margins at each level of the allergy diagnostics market are analyzed and readers can find detailed information on top importers and exporters as well as the value chain of the allergy diagnostics market.

Chapter 05 – Market Dynamics

The drivers and restraints impacting the growth of the allergy diagnostics market are explained in this chapter. Opportunities and ongoing trends in the allergy diagnostics market are also comprehensively discussed.

Chapter 06 – Allergy Diagnostics Market - Pricing Analysis

This chapter includes global as well as regional pricing analysis by product type. The pricing influencing factors are also explained in this chapter. The readers can understand the manufacturer level, distributor level as well as retail level pricing analysis for 2021 and 2031.

Chapter 07 – Allergy Diagnostics Market Demand Analysis and Forecast 2021-2031

This chapter includes a detailed analysis of the historical allergy diagnostics market (2017-2022), along with an opportunity analysis for the forecast period (2021-2031). Readers can also find the absolute $ opportunity for the current year (2021) and incremental opportunity for the forecast period (2021-2031).

Chapter 08 – Allergy Diagnostics Market Analysis 2017-2022 & Forecast 2021-2031 by Product Type

Based on product type, the allergy diagnostics market is segmented into fungal allergy diagnostic and neutral lactase enzymes. In this chapter, readers can find information about key trends and developments in the allergy diagnostics market and market attractiveness analysis based on the product type.

Chapter 09 – Allergy Diagnostics Market Analysis 2017-2022 & Forecast 2021-2031 by Allergen Type

Based on application, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In this chapter, readers can find information about key trends and developments in the forms of allergy diagnostics market and market attractiveness analysis based on the allergen type.

Chapter 10 – Allergy Diagnostics Market Analysis 2017-2022 & Forecast 2021-2031 by Test Type

Based on test, the allergy diagnostics market is segmented into In-vivo allergy tests, In-vitro allergy tests. In this chapter, readers can find information about key trends and developments in the forms of allergy diagnostics market and market attractiveness analysis based on the test type.

Chapter 11 – Allergy Diagnostics Market Analysis 2017-2022 & Forecast 2021-2031 by End user

Based on end user, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals, academic research institutes, and other end users. In this chapter, readers can find information about key trends and developments in the forms of allergy diagnostics market and market attractiveness analysis based on the end user.

Chapter 12 – Allergy Diagnostics Market Analysis 2017-2022& Forecast 2021-2031 by Region

This chapter explains how the allergy diagnostics market is anticipated to grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, and Middle East and Africa.

Visit For Report TOC @ https://www.futuremarketinsights.com/reports/allergy-diagnostics-market/table-of-content

Reasons to Buy the report

We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.

Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.

The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

FMI’s Healthcare Research Report:

Ocular Allergy Diagnostic System Market

Pneumonia Diagnostics Market

Pancreatic Cyst Diagnostics Market

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: [email protected]

For Media Enquiries: [email protected]

Press Release: https://www.futuremarketinsights.com/press-release/allergy-diagnostics-market

#Allergy Diagnostics Market

0 notes

decisionforsight · 3 years

Text

Global Hospital-Acquired Disease Testing Market

Global Hospital-Acquired Disease Testing Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

Global Hospital-Acquired Disease Testing Market held USD 1108.6 million in 2020 and is to grow with a CAGR of over 19.8% from 2020-2030. Hospital-acquired disease and nosocomial infection is a localized or general condition in patients that occurs during medical care due to adverse reactions caused by infectious toxin agents, which were absent at admission in hospitals. Hospital-acquired infections result in prolonged hospital stay, resistance to antimicrobials, long-term disabilities and increased mortality rates. Hospital-acquired disease-causing pathogens include viruses, fungal parasites and bacteria. Hospital-acquired diseases also include catheter-related infections of the blood stream, infections of the surgical site, ventilator-associated pneumonia, and urinary tract-associated infection.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020394

Market Dynamics and Factors :

Major driving factors for the market are increased government spending on the healthcare and medical sector, growth of hospital infrastructure in developing economies. Rapid and effective infection detection solutions not only help control the incidence of nosocomial infections but also control overall medical costs, hospital stays and death. Widespread availability of more sophisticated solutions for detecting infections, especially those under molecular diagnostics, and their proven efficiency in delivering faster results has resulted in increased demand for such products worldwide. Government initiatives and hospital-acquired infection control authorities focusing on boosting awareness about hospital-acquired infection and available therapies further drive demand for hospital-acquired infection tests. Furthermore, increasing prevalence of hospital acquired infections and growth in drug resistant pathogens is anticipated to drive the hospital acquired infection testing market trends.

Market Segmentation:

Global Hospital-acquired disease testing Market – By Testing Type

Urinary Tract Infection

Surgical Site Infection

Pneumonia Stents

Blood Stream Infection

Methicillin-resistant Staphylococcus Aureus (MRSA))

Others

Global Hospital-acquired disease testing Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020394

Geographic Analysis :

North America dominates the hospital-acquired disease testing market share with the large demand owing to advanced healthcare infrastructure. As per U.S. Department of Health and Human Services, hospital acquired infection prevention costs nearly around US$ 28.0 Bn to US$ 33.0 Bn per year. Therefore, to lower the burden on hospitals occurring due to prolonged patients stay in hospitals, many governments are taking steps to lower hospital acquired infection prevalence in the particular countries.

Competitive Scenario :

Global hospital-acquired disease testing market, is highly competitive, consists of a few major players. In terms of market share, currently few players hold the majority of the hospital-acquired disease testing market. Key companies are also expanding their manufacturing facilities to cater to growing demand for this drug globally. Key players enhancing the global Hospital-acquired disease testing market size include Hologic, Inc, bioMérieux SA, Abbott Laboratories, Siemens Healthcare, Alere, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hoffmann-La Roche Ltd, Diatherix Laboratories, Inc., Meridian Bioscience, Inc.

In 2019, F.Hoffmann-La Roche Ltd. grabbed U.S.. Food and Drug Administration (FDA) approval for a diagnostic test designed to detect the Methicillin-resistant Staphylococcus aureus (MRSA) bacteria, known as cobas vivoDx MRSA. The approval of is intended to control and prevent Methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in patients after long stay in hospitals.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020394

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Hospital-Acquired Disease Testing industry, although key threats, opportunities and disruptive technologies that could shape the Global Hospital-Acquired Disease Testing Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Hospital-Acquired Disease Testing Market most.

The data analysis present in the Global Hospital-Acquired Disease Testing Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Hospital-Acquired Disease Testing Market business.

The 2021 Annual Global Hospital-Acquired Disease Testing Market offers:

100+ charts exploring and analysing the Global Hospital-Acquired Disease Testing Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Hospital-Acquired Disease Testing Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020394

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: [email protected]

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

0 notes

pharmainsights · 2 years

Text

Fungal Pneumonia Market Report 2032 | DelveInsight

DelveInsight's "Fungal Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fungal Pneumonia, historical and forecasted epidemiology as well as the Fungal Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Fungal Pneumonia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Fungal Pneumonia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Fungal Pneumonia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Fungal Pneumonia market.

Fungal Pneumonia: An Overview

Fungal pneumonia is an infectious process in the lungs caused by one or more endemic or opportunistic fungi. Fungal infection occurs following the inhalation of spores, after the inhalation of conidia, or by the reactivation of a latent infection.

Learn more about Fungal Pneumonia, treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/report-store/fungal-pneumonia-market

Fungal Pneumonia Market

Several diseases are associated with P. aeruginosa, such as meningitis, pneumonia (ventilator-assisted pneumonia and community-acquired pneumonia), cystic fibrosis, urinary tract infection, and others. The associated disease are treated with different antibiotics as monotherapy or combination of antibiotics. Ceftazidime is a preferable antibiotic for the treatment of meningitis because of its high penetration into the subarachnoid space and the high susceptibility of pseudomonas. In pneumonia most experts recommend taking two anti-pseudomonal antibiotics and then de-escalating to monotherapy.

Among the US Food Drug and Administration (FDA) approved drugs, recently approved monotherapies and combination regimens includes Zerbaxa (ceftolozane and tazobactam), Avycaz (ceftazidime and avibactam), whereas, in monotherapy, Fetroja, Cayston (aztreonam for inhalation solution), and others are used for the treatment of Fungal Pneumonia infections. Many off-label antibiotics are also used in the treatment of Fungal Pneumonia infections.

The increase in the R&D activities and the emergence of multi-drug resistant pathogens along with the burden of antibiotic-resistant infections will contribute to the growth of Fungal Pneumonia infections market.

Expected launch of SPR994 and other drugs for treating Fungal Pneumonia infections shall fuel the growth of the market size in the upcoming years.

According to DelveInsight, the Fungal Pneumonia market in 7MM is expected to witness a major change in the study period 2019-2032.

Request a sample and discover more about the report offerings at:

Fungal Pneumonia Epidemiology

The Fungal Pneumonia epidemiology section provides insights into the historical and current Fungal Pneumonia patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Fungal Pneumonia market report also provides the diagnosed patient pool, trends, and assumptions.

Pseudomonas Aeruginosa Epidemiology Insights:

As per the findings from secondary domain, males are most commonly affected in the case of Fungal Pneumonia Infection.

The National Nosocomial Infections Surveillance System (NNIS) reports P. aeruginosa to be the second most common organism isolated in nosocomial pneumonia, the third most common organism isolated in both urinary tract infection (UTI) and surgical site infection, and the fifth most common organism isolated from all sites of nosocomial infection.

Fungal Pneumonia Emerging Therapy Assessment

The dynamics of Fungal Pneumonia Infection market is anticipated to change in the coming years, owing to the increase in the initiatives toward control of drug-resistance, the emergence of multi-drug resistance pathogens, and also expects the launch of emerging therapies during the forecast period of 2020–2032. Some of the key players in the therapeutic market of Fungal Pneumonia Infections at a global level are Biomex, Inc., Armata Pharmaceuticals, vectorB2B, and others.

This section focuses on the uptake rate of the potential Fungal Pneumonia drugs recently launched in the Fungal Pneumonia market or expected to be launched in 2019-2032. The analysis covers the Fungal Pneumonia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Fungal Pneumonia Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Fungal Pneumonia market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Fungal Pneumonia Pipeline Development Activities

The Fungal Pneumonia report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Fungal Pneumonia key players involved in developing targeted therapeutics.

Fungal Pneumonia Therapeutics Assessment

Major key companies are working proactively in the Fungal Pneumonia Therapeutics market to develop novel therapies which will drive the Fungal Pneumonia treatment markets in the upcoming years.

Fungal Pneumonia Report Key Insights

1. Fungal Pneumonia Patient Population

2. Fungal Pneumonia Market Size and Trends

3. Key Cross Competition in the Fungal Pneumonia Market

4. Fungal Pneumonia Market Dynamics (Key Drivers and Barriers)

5. Fungal Pneumonia Market Opportunities

6. Fungal Pneumonia Therapeutic Approaches

7. Fungal Pneumonia Pipeline Analysis

8. Fungal Pneumonia Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Fungal Pneumonia Market

Table of Contents

1. Key Insights

2. Executive Summary

3. Fungal Pneumonia Competitive Intelligence Analysis

4. Fungal Pneumonia Market Overview at a Glance

5. Fungal Pneumonia Disease Background and Overview

6. Fungal Pneumonia Patient Journey

7. Fungal Pneumonia Epidemiology and Patient Population

8. Fungal Pneumonia Treatment Algorithm, Current Treatment, and Medical Practices

9. Fungal Pneumonia Unmet Needs

10. Key Endpoints of Fungal Pneumonia Treatment

11. Fungal Pneumonia Marketed Products

12. Fungal Pneumonia Emerging Therapies

13. Fungal Pneumonia Seven Major Market Analysis

14. Attribute Analysis

15. Fungal Pneumonia Market Outlook (7 major markets)

16. Fungal Pneumonia Access and Reimbursement Overview

17. KOL Views on the Fungal Pneumonia Market

18. Fungal Pneumonia Market Drivers

19. Fungal Pneumonia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Get the Detailed TOC of the Fungal Pneumonia Market report here: https://www.delveinsight.com/report-store/fungal-pneumonia-market

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Kritika Rehani

[email protected]

+1(919)321-6187

www.delveinsight.com

#Fungal Pneumonia market #Fungal Pneumonia market research #Fungal Pneumonia market insight #Fungal Pneumonia pipeline #Fungal Pneumonia treatment #Fungal Pneumonia epidemiology #Fungal Pneumonia drugs and medicine #Fungal Pneumonia epidemiology insights

1 note · View note

kritikarehani · 3 years

Text

Osteomyelitis Market Size, Share, Trends, Epidemiology and Competitive Insights Report 2030

Osteomyelitis is a bone infection, usually caused by bacteria that can be either acute or chronic. This disorder occurs as a result of an infection in one part of the body that is transported through the bloodstream to a bone in a distant location. Among children and teens, the long bones of the legs and arms are most frequently affected. In adults, osteomyelitis most often affects the vertebrae of the spine and the hips.

DelveInsight's "Osteomyelitis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Osteomyelitis, historical and forecasted epidemiology as well as the Osteomyelitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Osteomyelitis Disease Overview

Acute osteomyelitis is a serious bone inflammation that can result from a previous trauma, puncture wound, surgery, bone fracture, abscessed tooth, or infection of soft tissue, the ear or sinus. In children, it usually affects the long bones, especially the growth center (epiphysis) at the end of the shaft. In adults, bones of the spinal column (vertebra) are often affected.

The DelveInsight Osteomyelitis market report gives a thorough understanding of the Osteomyelitis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Click here to read more on Osteomyelitis Market.

Osteomyelitis Epidemiology Insights

Osteomyelitis is an infection frequently caused by Staphylococcus bacteria. It is transmitted through the bloodstream from one area of the body to another. In descending order of frequency, the bacteria most often associated with this disorder are Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes.

The Osteomyelitis epidemiology division provide insights about historical and current Osteomyelitis patient pool and forecasted trend for every seven major countries.

Key Findings

· Osteomyelitis is a bacterial or fungal infection of the bone. Osteomyelitis affects about two out of every 10,000 people.

Read more: Osteomyelitis Epidemiology Insights.

Osteomyelitis Drug Chapters

The dynamics of Osteomyelitis market is anticipated to change in the coming years owing to the rising awareness of the disease, and incremental healthcare spending across the world. The current pipeline of Osteomyelitis is limited as only few companies are working on Osteomyelitis. This provides an opportunity to the other companies to enter in the market.

Key players in the therapeutic market of Osteomyelitis are Debiopharm, Adaptive phage therapeutic, Arrevus, Allergan and others.

To know more about emerging therapies and key pharma players, visit https://www.delveinsight.com/report-store/osteomyelitis-pipeline-insight

Osteomyelitis Market Outlook

Osteomyelitis is a challenging condition to treat. It is seen mostly after open fractures or in implant-related infections following treatment of fractures and prosthetic joint replacements. The goal of treatment of osteomyelitis is to complete eradication of infection while preserving the soft-tissue envelope, healing of bone segment, and preservation of limb length and function.

In the current market scenario, the standard treatment for Osteomyelitis includes use of Oral antibiotics and Surgery. Oral antibiotics that have been proved to be effective include clindamycin, rifampin, trimethoprim-sulfamethoxazole, and fluoroquinolones. Clindamycin is given orally after initial intravenous (IV) treatment for 1-2 weeks and has excellent bioavailability.

The Osteomyelitis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Osteomyelitis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

According to DelveInsight, Osteomyelitis market in 7MM is expected to change in the study period 2017-2030.

Related Reports:

· Osteomyelitis - Epidemiology Forecast to 2030

· Osteomyelitis - Pipeline Insights, 2021

Visit our Insightful Press Release @https://icrowdnewswire.com/2021/05/03/rich-insights-into-end-stage-renal-disease-esrd-market-epidemiology-segmentation-pipeline-therapies-and-major-key-players-involved/

About DelveInsight:

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

#Osteomyelitis market #Osteomyelitis key companies #Osteomyelitis therapies #Osteomyelitis market share #Osteomyelitis market size #Osteomyelitis market research report #Osteomyelitis market trends #Osteomyelitis market insights #Osteomyelitis treatment #Osteomyelitis diagnosis #Osteomyelitis epidemiology insights #Osteomyelitis pipeline therapies

0 notes

leonfrancisblog · 3 years

Text

Healthcare-Associated Infection (HAI) Market Global Industry Analysis Size, Share, Trends and Profitable Segments Breakdown and Detailed Analysis of Current and Future Industry Figures till 2027

Healthcare-associated infection (HAI) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The below data points provided are only related to the companies’ focus related to healthcare-associated infection (HAI) market. healthcare-associated infection (HAI) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research healthcare-associated infection (HAI) market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Healthcare-associated infection (HAI) depicts its meaning from the name, they are commonly acquired infections induced in the patients from external sources in the hospitals or healthcare centers. Owing to this factor all the type of healthcare centers such are hospitals, clinics, pathologies are adopting measures to reduce the possibilities of infections and contamination by sterlizing the services offered in these point of care institutes. Market growth of HAI is directly proportional to the contagious ratio which is critically required to control, can be achieved through certain standard adoption while examination of patients. Namely molecular diagnostic testing and accelerating improvements in the diagnostic testing sector will propel the market growth and success factor of healthcare-associated infection (HAI) solely.In November 2019, the visual input to drive the market can be observed in the recent acquisition established between Beijing Hanmi Pharmaceutical Co., Ltd. and Innovent Biologics, Inc. The prominent healthcare enterprises joined together for the business venture in developing and commercializing better quality medicines for treating metabolic, oncology and, autoimmune and other major contagious diseases and asserts to continue the collaboration with the focus of catering high-level clinical and market advancements.

Global Healthcare-associated infection (HAI) Market By Product (Consumables, Analyzers/Instruments), By Pathogen (Viral, Bacterial and Fungal), By Treatment (Sterilization, Chemical, Radiation), By Infections (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, Bloodstream Infections, Gastrointestinal Infections, Respiratory infections. Other Healthcare-associated Infections), By Diagnostic Tests (Traditional Diagnostics, and Molecular Diagnostics) By End Use (Hospitals, Clinics, ASCs, and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027 Healthcare-associated infection (HAI) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 54.57 billion by 2027 growing at the annual growth rate of (CAGR) 8.0% in the above-mentioned forecast period. The spreading knowledge amongst the physicians and patients about the advantages blended with the usage of healthcare-associated infection (HAI) has been instantly reshaping the growth of healthcare-associated infection (HAI) market.

Get More Info Sample Request on Healthcare-Associated Infection (HAI) Market: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-healthcare-associated-infection-hai-market

Healthcare-associated infection (HAI) Market Country Level Analysis:

Healthcare-associated infection (HAI) market is analyzed and market size insights and trends are provided by country, product pathogens, and method of treatment, infections, diagnostic tests, and end use as referenced above.

The country section of the healthcare-associated infection (HAI) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The countries covered in the healthcare-associated infection (HAI) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. North America anticipated beholding skyward germination in denominations of revenue, with prime players concentrating on flourishing innovations and developed contagious infection diagnostics goods adding to the yield of the market in the outlook period of 2020 to 2027 due to the focus of various established market players to expand their presence in this particular region. Following the same trails of exceptional increment European regions such as Italy, Spain, and Portugal are inducing healthcare-associated infection (HAI) modules to gain high stakes in market.

Global Market Scope and Market Size of Healthcare-associated infection (HAI)

Healthcare-associated infection (HAI) market is segmented of the basis of product, pathogens, method of treatment, infections, diagnostic tests, and end use. The growth amongst these sections will help you interpret lean growth segments in the enterprises, and will provide the users a relevant market overview and market penetrations to help them in making strategic decision for the identification of core market demands.

Based on product, the healthcare-associated infection (HAI) market is segmented into consumables, and analyzers/instruments. Based on pathogens, the healthcare-associated infection (HAI) market is segmented into viral, bacterial, and fungal. Bifurcations on the basis of treatment are sterilization, chemical, and radiation. Based on the type of infections, healthcare-associated infection (HAI) market is segmented into urinary tract infections, surgical site infections, hospital-acquired pneumonia, bloodstream infections, gastrointestinal infections, respiratory infections and other healthcare-associated infections. Segmentation on the basis of diagnostics test in the healthcare-associated infection (HAI) market is traditional diagnostics, molecular diagnostics. Healthcare-associated infection (HAI) market has also been segmented based on the end use into hospitals, clinics, ASCs, others.

The major business players and prime market dominators covered in the healthcare-associated infection (HAI) market report are HORIBA, Ltd., BD., bioMérieux, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience, QIAGEN, ASP, Fortive, Johnson & Johnson Services, 3M, STERIS plc., Getinge AB., Cantel Medical., Belimed, Trinity Biotech, DiaSorin, OpGen, Accelerate Diagnostics, Thermo Fisher Scientific, Bio-Rad, Luminex Corporation., Quidel Corporation. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Healthcare-Associated Infection (HAI) Market:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Get Table of Content: https://www.databridgemarketresearch.com/toc/?dbmr=global-healthcare-associated-infection-hai-market

Reasons for buying this Global Healthcare-Associated Infection (HAI) Market:

Laser Capture Global Healthcare-Associated Infection (HAI) Market aids in understanding the crucial product segments and their perspective.

Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Laser Capture Global Healthcare-Associated Infection (HAI) Market.

Even the Laser Capture Global Healthcare-Associated Infection (HAI) Market economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.

This report provides a more rapid standpoint on various driving facets or controlling Medical Robotic System promote advantage.

This worldwide Locomotive report provides a pinpoint test for shifting dynamics that are competitive.

The key questions answered in this report:

What will be the Market Size and Growth Rate in the forecast year?

What is the Key Factors driving Laser Global Healthcare-Associated Infection (HAI) Market?

What are the Risks and Challenges in front of the market?

Who are the Key Vendors in Global Healthcare-Associated Infection (HAI) Market?

What are the Trending Factors influencing the market shares?

What is the Key Outcomes of Porter’s five forces model

Access Full Report: https://www.databridgemarketresearch.com/reports/global-healthcare-associated-infection-hai-market

Browse Related Report:

Vacuum Blood Collection Tube Market

Egypt Syringes, Auto Disable Syringe and IV Cannulas Market

Ophthalmic Viscoelastic Devices (Ovd) Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Market by Type Market Development Market Forecast Market Size Future Innovation Market Future Trends Market Share Market Demand Market Growt

0 notes

udaycmi · 3 years

Link

Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-sample

Request for Discount on This Report @https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-discount-pricing

Polaris Market Research has segmented the global Meningitis Diagnosis and Treatment Market on the basis of type, diagnostic test, end user and region:

Meningitis Diagnosis and Treatment by Type Outlook (Revenue, USD Million, 2015 – 2026)

Bacterial

Fungal

Viral

Meningitis Diagnosis and Treatment by Diagnostic Test Outlook (Revenue, USD Million, 2015 – 2026)

PCR Assay

Lateral Flow Assay

Latex Agglutination Tests

ELISA Tests

Culture Test

Meningitis Diagnosis and Treatment by End-User Outlook (Revenue, USD Million, 2015 – 2026)

Hospitals

Diagnostic Centers

Others

Meningitis Diagnosis and Treatment Regional Outlook (Revenue, USD Million, 2015 – 2026)

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

France

Italy

Spain

Belgium

Russia

Netherlands

Rest of Europe

China

India

Japan

Korea

Singapore

Malaysia

Indonesia

Thailand

Philippines

Brazil

Mexico

Argentina

Rest of LATAM

UAE

Saudi Arabia

South Africa

Rest of MEA

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

sapanas · 4 years

Text

Hospital Acquired Infections Market 2020 Global Industry Size, Analysis & Opportunities

Hospital Acquired Infections Market Overview:

The global market for hospital acquired infections are expected to surpass a valuation of USD 36.16billion by 2022 with a CAGR of 7.3% during the forecast period of 2017 to 2022. Market Research Future (MRFR) discussed several factors in the report that would provide ample scope to the market to register strong growth in the coming years.

The growing demand for safety against various attacks from bacteria, virus, and others, susceptible patients in the hospital with weak immunity, better inclusion of drugs. Hike in technological support, and others are expected to boost the market prospect of the hospital acquired infections. Lack of patient handling awareness can also prevent growth for the market.

Read more news on: https://www.medgadget.com/2019/10/hospital-acquired-infections-hai-market-to-expand-phenomenally-industry-analysis-by-method-of-treatment-infection-type-size-growth-share-top-companies-regional-forecast-to-2022.html

However, the global market can suffer from the growing microbial resistance and increase use of glass and ceramic in hospitals.

Hospital Acquired Infections Market Segmentation:

The stud on the global hospital acquired infections market includes pathogen types and treatment method, nd infection type. These segments have data that is helpful in getting insights. These insights are reliable as they have been backed by several figures and factors. It would help in the development of strategies.

By pathogen types, the study on the global market for hospital acquired infections market has been segmented into viral, bacterial and fungal. The viral segment is getting tailwinds due to the impact of several contagious viral diseases.

By treatment method, the study on the global hospital acquired infections market analysis has been segmented into chemical, sterilization, and radiation. The sterilization segment is getting good thrust due to its use for the surgical equipment.

By infection type, the global market study on the hospital acquired infections has been segmented into blood stream infections, urinary tract infections, gastrointestinal infections, surgical site infections, and respiratory infections. The respiratory infections segment is getting ample traction from the market.

Hospital Acquired Infections Market Regional Analysis:

The Americas would be leading the global market as the structural superiority of the region is expected to boost the revenues. Also, hike in investment to ensure better treatment facilities can influence the regional market. The US and Canada would contribute the most to take the regional market forward.

Hospital Acquired Infections Market Competitive Landscape:

The global market for hospital acquired infections is expecting boost from companies like 3M Company, Becton Dickinson and company, Belimed AG, Advanced Sterilization Products, Getinge AB, Cantel Medical Corp., STERIS Corporation, and others. These companies will launch their strategic moves including various mergers, acquisitions, collaborations, and others. These strategies often create better scope for the market to expand and the companies benefit from that by making more profits. Other tactical measures like launching strategy, innovations, and a hike in research and development sector is all set to boost the global market outcome. MRFR’s recording of these latest changes can inspire better strategies in the coming years.

Hospital Acquired Infections Industry News:

In May 2020, studies published on the effective application of Vibativ have been published and it shows positive results for the medicine. Vibativ is a FDA approved anti-infective drug that is used for the treatment of certain serious bacterial infections that includes bacterial pneumonia both hospital-acquired and ventilator-associated. The medicine also finds substantial application in the treatment of complicated skin and skin structure infections.

The global hospital acquired infections market is getting amply boosted by the recent COVID-19 pandemic outbreak. This is primarily due to the contagious nature of the disease that spreads almost in no time. Countries are trying to contain it owing to which the market for hospital acquired infections is growing.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/hospital-acquired-infections-market-2576

#Hospital Acquired Infections Market #Hospital Acquired Infections Market Size #Hospital Acquired Infections Market Share #Hospital Acquired Infections Market Growth #Hospital Acquired Infections Market Anaysis

0 notes

industry365 · 3 years

Text

Meningitis Diagnosis and Treatment Market-pr Is Expected To Reach New Growth Revenues During 2021-2028

Download sample: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-sample

Get Discount offer: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-discount-pricing

Bacterial

Fungal

Viral

Meningitis Diagnosis and Treatment by Diagnostic Test Outlook (Revenue, USD Million, 2015 – 2026)

PCR Assay

Lateral Flow Assay

Latex Agglutination Tests

ELISA Tests

Culture Test

Meningitis Diagnosis and Treatment by End-User Outlook (Revenue, USD Million, 2015 – 2026)

Hospitals

Diagnostic Centers

Others

Meningitis Diagnosis and Treatment Regional Outlook (Revenue, USD Million, 2015 – 2026)

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

U. S.

Canada

Germany

France

Italy

Spain

Belgium

Russia

Netherlands

Rest of Europe

China

India

Japan

Korea

Singapore

Malaysia

Indonesia

Thailand

Philippines

Brazil

Mexico

Argentina

Rest of LATAM

UAE

Saudi Arabia

South Africa

Rest of MEA

Buy Now: https://www.polarismarketresearch.com/checkouts/5441

0 notes

omgsampada · 4 years

Link

Sepsis diagnostics market is anticipated to reach over USD 1033.02 Million by 2026 according to a new study published by Polaris Market Research.

Sepsis is a type of fatal organ dysfunction ailment rises when the body responses to an infection to its own organs and tissues and organs. This disorder can be triggered due to the weakened immune system, kidney or liver disease, chronic illness such as cancer, and severe wounds. Sepsis can be of two types septic shock in which there are the indications of severe sepsis including a low blood pressure and another is severe sepsis when there’s organ failure.

Request for sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-sample

The high occurrence of people suffering sepsis and the demand for appropriate diagnosis and treatment is anticipated to bolster the demand for the sepsis diagnostics market. In addition, rising number of hospital-acquired infections (HIA) are expected to support the growth of the market during the forecast period. Hospital-acquired infections primarily include surgical site and urinary tract infections, which result in sepsis. According to the World Health Organizations (WHO), 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed economies. This, in turn, demands proper diagnosis, further bolstering the market growth. On the other hand, pneumonia is also a significant driving factor for the high demand of sepsis diagnostics market as it is one of the major causes of septic shock.

The global Sepsis Diagnostics Market is segmented on the basis of products, technology, pathogen, testing type, and geography. On the basis of products, the global Sepsis Diagnostics Market is segmented into Instruments, Blood Culture Media, and Assay Kits and Reagents. In 2017, the blood culture media was projected to be the major market sharing segment during the forecast period. The cost-effectiveness mode of the test is the primary reason for the major market share. In addition, due to the lower cost, the blood culture method is also considered as the gold standard method. On the basis of technology, the global sepsis diagnostics market is segmented into Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry. The microbiology segment was estimated to be the dominating segment due to the fact that it permits the identification and quantitative detection of microbes for sepsis diagnosis through the application of culture media tests. On the basis of the pathogen, the global sepsis diagnostics market is segmented into Bacterial Sepsis and Fungal Sepsis. The bacterial sepsis id further categorized into, gram-positive bacteria and gram-negative bacteria. In 2017, the bacterial sepsis segment is anticipated to dominate the segment. This is due to the patients suffering from the blood poisoning disease is a generally considered as a casualty of bacterial infection. On the basis of test type, the global sepsis diagnostics market is segmented into Laboratory Testing and PoC Testing. In 2017, the laboratory testing type is estimated to dominate the market.

Some major key players in global Sepsis Diagnostics Market include Becton, Dickinson and Company, bioMérieux SA, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Cepheid Inc., Bruker Corporation, and Nanosphere, Inc. among others.

Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes